Table 2.

The correlation of Ataxin-3 expression (IHC) with clinicopathological parameters

parameters	Ataxin-3
	-	+	++	F/X2	P
Age (y)
< 60	85	164	67	0.744	0.689
≥ 60	61	119	40
Gender
male	101	199	75	0.061	0.970
female	45	84	32
Tumor site
Upper 1/3	34	60	26	4.097	0.661
Middle 1/3	37	66	31
Lower 1/3	71	143	48
Two-thirds or more	4	14	2
Tumor size (cm)
< 5	76	140	71	9.079	0.011
≥ 5	70	143	36
Borrmann type
Borrmann 0	9	9	3	8.308	0.078
Borrmann I~II	48	69	36
Borrmann III~IV	89	205	68
Lauren’s classification
Intestinal	28	120	72	83.952	0.000
Mixed	45	100	27
Diffuse	73	63	8
Histological differentiation
Well	1	5	4	30.117	0.000
Moderate	10	57	33
Poor	135	221	70
Invasion depth
T1	14	14	5	7.849	0.249
T2	10	13	10
T3	34	79	29
T4	88	177	63
Lymph node metastasis
N0	62	110	43	1.473	0.961
N1	25	55	19
N2	30	57	19
N3	29	61	26
Distant metastasis
Yes	124	245	98	2.604	0.272
No	22	38	9
TNM stage
I	16	22	12	5.413	0.492
II	55	105	37
III	53	119	49
IV	22	37	9
p53
-	65	86	33	9.729	0.045
+	29	69	23
++ to +++	52	128	51